Our explorations

Home Our offer Succeed in your product launch with a robust sales and marketing strategy

Succeed in your product launch with a robust sales and marketing strategy

Alcimed supports its customers in their product launches throughout the world. Once the innovation and proof-of-concept phases are completed, we offer complete strategic and operational support to our clients to successfully launch and market their new product.

Have a project? Contact our team!

What is a product launch?

A product launch is the first initiative to put a product on the market. Launching a new product is therefore an extremely important marketing and commercial step, which requires rigorous preparation and excellent coordination between the different actions to be carried out to make your product available for purchase by your future consumers.

The quality of your product launch will determine the level of awareness of your brand, your first sales, or your first customer satisfaction feedback, … and thus a first evaluation of your return on investment. The development of a robust product launch strategy is therefore essential to guarantee your success.

 

Product launch Agency Consulting firm Experts Specialists

How our team can help you achieve a successful product launch?

To help our clients successfully prepare their product launch initiatives, our teams are involved from upstream marketing analysis and strategy (regulatory analysis, competitive environment mapping, choice of market positioning and market segments, estimation of market potential, etc.), to marketing strategy (choice of business model, distribution channels, price positioning, identification of potential partners, etc.), through to the first contracts and first sales (assistance with prospecting, business development, etc.).

Contact us!

Examples of product launch strategies conducted by our team: zoom on some clients cases

We supported a pharmaceutical company in the launch of a combined offer, which consisted in adding a communication platform between the patient and healthcare professionals to a medical device. By analyzing the receptiveness of the medical community to this new combined offer, Alcimed enabled its client to establish the most appropriate marketing strategy for the launch of its product. This was then concretized from an operational point of view by accompanying the sales teams in the construction of their communication supports (presentation materials, sales pitch,...) in order to facilitate the integration of the messages and their diffusion to the different communities of healthcare professionals.
We assisted a major company in the agri-food industry in developing a marketing campaign plan to promote the health benefits of alcohol-free beer in preparation for the new products launch. By developing a set of marketing arguments based on an in-depth scientific analysis, and identifying market events on the theme of nutrition and potential influencers, Alcimed enabled its client to prepare its product launches plan in more than ten markets worldwide.
Alcimed assisted an American biopharmaceutical client in defining the launch strategy of its orphan drug in Europe, and then in structuring a concrete and operational plan, both at the level of the European region and at the level of each targeted country. The launch plan is a roadmap for each of the company's key functions (medical, marketing, production, regulatory, sales) and covers the period from pre-launch (before obtaining the MA - Marketing Authorization) to the first sales. Today, our team is still involved in regularly updating the first plan defined with our client, according to internal or external developments around this orphan drug in several European countries.
We assisted a leading company in the field of CAR-T therapies in preparing the launch of its new treatment and in defining its market access strategy in the US, Canada and Europe. CAR-Ts are highly personalized technologies that require a high level of specialization to be delivered to patients, and therefore not all healthcare facilities are ready to administer them. In this context, and in order to define the market access strategy for its new treatment, we helped our client to:

  1. Understand and identify which centers would have the capacity to deliver CAR-T.
  2. Analyze the bottlenecks to approval this new product in the relevant markets.
  3. Consequently, define the actions to be implemented to ensure access to their new CAR-T therapy.

Following an investigation of over 200 healthcare centers in the US, Canada and Europe, our analysis enabled us to recommend to our client the key next steps to take to ensure their new product launch, including developing the skills of each center and facilitating rapid market access for their new treatment.

Founded in 1993, Alcimed is an innovation and new business consulting firm, specializing in innovation driven sectors: life sciences (healthcare, biotech, agrifood), energy, environment, mobility, chemicals, materials, cosmetics, aeronautics, space and defence.

Our purpose? Helping both private and public decision-makers explore and develop their uncharted territories: new technologies, new offers, new geographies, possible futures, and new ways to innovate.

Located across eight offices around the world (France, Europe, Singapore and the United States), our team is made up of 220 highly-qualified, multicultural and passionate explorers, with a blended science/technology and business culture.

Our dream? To build a team of 1,000 explorers, to design tomorrow's world hand in hand with our clients.

TELL US ABOUT YOUR UNCHARTED TERRITORY

    You have a project and want to discuss it with our explorers, write us ! One of our explorers will contact you shortly.

     

    Our explorations